Evvy
A women’s health platform providing at-home vaginal microbiome testing and data-driven clinical insights.
Evvy is a biotech & life sciences company based in US, founded in 2021. It has raised $40 million in disclosed funding. Its latest round was a Series B of $40 million in September 2026.
Overview
No overview yet. It is written from sources once there are enough of them.
Funding
Total disclosed: $40M across 1 round. Computed only from sourced rounds.
Investors
Questions and answers
What does Evvy do?
A women’s health platform providing at-home vaginal microbiome testing and data-driven clinical insights.
How much has Evvy raised?
Evvy has raised $40 million in disclosed funding across 1 round tracked by OSH.
Who has invested in Evvy?
Investors in Evvy include Catalio Capital Management.
When and where was Evvy founded?
Evvy was founded in 2021 and is based in US.
Timeline
Founded
Sources
- 1.Evvy raises $40M as it seeks to further women’s health research with vaginal microbiome data — TechCrunch Venture, Sep 15, 2026